While annual HIV surveillance reports released by the CDC in May showed that the number of estimated new HIV infections per ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...

The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.

Following the passing of popular Benga songstress Princess Jully this past weekend, fans and Kenyans have come out to honour ...

In order to counter such stigma and discrimination, women living with HIV and Hepatitis B came together at The Voice of ...

Babies born to mothers with HIV should receive HIV drugs within six hours after birth to prevent mother-to-child transmission ...

Measures to reduce the rate of transmission include free condoms, STI checks and Pre-exposure prophylaxis (PreP).

In June, we heard what could be this year's biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. Findings from a second large study of the jab has now confirmed that it works.

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...

Within two to four weeks after HIV infection, many, but not all, people develop flu-like symptoms, including fever, swollen ...